DAM
MGNX icon

Doheny Asset Management’s MacroGenics MGNX Stock Holding History

Doheny Asset Management’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-23,200
Closed -$694K – 113
2016
Q3 		$694K Hold
23,200
– – 0.36% 63
2016
Q2 		$626K Hold
23,200
– – 0.31% 66
2016
Q1 		$435K Sell
23,200
-6,150
-21% -$117K 0.22% 71
2015
Q4 		$909K Buy
+29,350
New +$892K 0.44% 58

Other funds holding MGNX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BRC
Blue Ridge Capital New York $215M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Doheny Asset Management's MGNX Position: Q4 2016 in Review

Doheny Asset Management sold out of MacroGenics (MGNX) in Q4 2016, closing a stake of 23,200 shares — an estimated $694K sold.

Doheny Asset Management first reported a position in MGNX in Q4 2015 and held it in 4 quarters. The position peaked at $909K in Q4 2015. 131 funds tracked by Wall St. Rank hold MGNX as of Q4 2016.

  • Doheny Asset Management reported no remaining MacroGenics position as of Q4 2016 after selling out during the quarter.
  • Doheny Asset Management sold 23,200 MacroGenics shares in Q4 2016, an estimated $694K.
  • Doheny Asset Management first reported a position in MacroGenics in Q4 2015 and held it in 4 quarters.
  • Doheny Asset Management's MacroGenics position peaked at $909K in Q4 2015.
  • 131 funds tracked by Wall St. Rank held MacroGenics as of Q4 2016.

Based on Doheny Asset Management's 13F filing for Q4 2016, filed 8 Feb 2017.